Abdul Mabood Khalil Muhammad, Iftikhar Nadia, Hussain Syed Ather, Tan Jackson
Section of Nephrology, Department of Medicine, Aga Khan University Hospital, Stadium Road, Karachi, 74800, Pakistan.
RIPAS Hospital Brunei Darussalam, Bandar Seri Begawan, Brunei.
CEN Case Rep. 2013 May;2(1):41-45. doi: 10.1007/s13730-012-0036-z. Epub 2012 Sep 28.
Mixed connective tissue disease (MCTD) is a rheumatic disease with a combination of multiple connective tissue disorders, which includes dermatomyositis or polymyositis, systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis and Sjögren's syndrome. It affects various organs of the body, which includes the lungs, heart, kidneys, joints, muscles and the haematological system. Here, we report a case of MCTD consisting of scleroderma, Sjögren's syndrome and polymyositis complicated by scleroderma renal crisis (SRC) but with negative anti-nuclear antibody (ANA), anti-Scl 70 and anti-centromere antibodies. The patient was started on captopril for the treatment of SRC but developed chronic kidney disease despite adequate blood pressure control with angiotensin-converting enzyme inhibitor (ACEi).
混合性结缔组织病(MCTD)是一种具有多种结缔组织疾病组合的风湿性疾病,包括皮肌炎或多发性肌炎、系统性硬化症、系统性红斑狼疮、类风湿关节炎和干燥综合征。它会影响身体的各个器官,包括肺、心脏、肾脏、关节、肌肉和血液系统。在此,我们报告一例由硬皮病、干燥综合征和多发性肌炎组成的MCTD,并发硬皮病肾危象(SRC),但抗核抗体(ANA)、抗Scl 70抗体和抗着丝点抗体均为阴性。该患者开始使用卡托普利治疗SRC,但尽管使用血管紧张素转换酶抑制剂(ACEi)血压控制良好,仍发展为慢性肾脏病。